{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:52:11Z","timestamp":1792266731692,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jdcr.2026.06.052","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:48:16Z","timestamp":1784098096000},"page":"260-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of mogamulizumab-associated rash with granuloma annulare-like features in a patient with Sezary syndrome: A case report and review of the literature"],"prefix":"10.1016","volume":"75","author":[{"given":"Jenna K.","family":"Currier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ghaferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Murakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jdcr.2026.06.052_bib1","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jdcr.2026.06.052_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.abd.2020.12.007","article-title":"Mycosis fungoides and S\u00e9zary syndrome: focus on the current treatment scenario","volume":"96","author":"Sanches","year":"2021","journal-title":"An Bras Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2026.06.052_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamadermatol.2021.0877","article-title":"Clinical characterization of mogamulizumab-associated rash during treatment of mycosis fungoides or S\u00e9zary syndrome","volume":"157","author":"Hirotsu","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.06.052_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13555-021-00624-7","article-title":"Dermatologic events associated with the anti-CCR4 antibody mogamulizumab: characterization and management","volume":"12","author":"Musiek","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"12","key":"10.1016\/j.jdcr.2026.06.052_bib5","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/PAS.0000000000001587","article-title":"Histopathologic characterization of mogamulizumab-associated rash","volume":"44","author":"Wang","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.jdcr.2026.06.052_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archdermatol.2009.55","article-title":"Granuloma annulare treated with rifampin, ofloxacin, and minocycline combination therapy","volume":"145","author":"Marcus","year":"2009","journal-title":"Arch Dermatol"},{"issue":"Supplement 1","key":"10.1016\/j.jdcr.2026.06.052_bib7","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1182\/blood-2022-166887","article-title":"Mogamulizumab-associated rash (MAR) correlates with longer progression free survival in cutaneous T cell lymphoma (CTCL)","volume":"140","author":"Hu","year":"2022","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jdcr.2026.06.052_bib8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamadermatol.2019.0369","article-title":"Mogamulizumab-associated cutaneous granulomatous drug eruption mimicking mycosis fungoides but possibly indicating durable clinical response","volume":"155","author":"Chen","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdcr.2026.06.052_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jdcr.2021.11.022","article-title":"Effective treatment of mogamulizumab-induced head and neck dermatitis with fluconazole in a patient with peripheral T-cell lymphoma","volume":"20","author":"Asokan","year":"2022","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.jdcr.2026.06.052_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjd.20708","article-title":"Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series","volume":"186","author":"Trum","year":"2022","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jdcr.2026.06.052_bib11","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1111\/jdv.18284","article-title":"Mogamulizumab-induced granulomatous dermatitis of the scalp: a distinct entity associated with clinical response","volume":"36","author":"Pacaud","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.06.052_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/bjd.21030","article-title":"Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides","volume":"187","author":"Wang","year":"2022","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jdcr.2026.06.052_bib13","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.2021013341","article-title":"Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients","volume":"139","author":"de Masson","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jdcr.2026.06.052_bib14","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1111\/jdv.18741","article-title":"Mogamulizumab-associated rash simulating lupus miliaris disseminatus faciei","volume":"37","author":"Mitteldorf","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jdcr.2026.06.052_bib15","first-page":"1079","article-title":"Mogamulizumab-associated rash \u2013 case series and review of the literature","volume":"22","author":"Hansen","year":"2024","journal-title":"J Dtsch Dermatol Ges"},{"issue":"9","key":"10.1016\/j.jdcr.2026.06.052_bib16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/jdv.14797","article-title":"Mogamulizumab-induced photosensitivity in patients with mycosis fungoides and other T-cell neoplasms","volume":"32","author":"Masuda","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jdcr.2026.06.052_bib17","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1111\/jdv.18831","article-title":"Mogamulizumab-associated rashes, their presentation and prognostic significance: a single-centre retrospective case series analysis","volume":"37","author":"Pileri","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626004005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626004005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:39:38Z","timestamp":1792265978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626004005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":17,"alternative-id":["S2352512626004005"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.06.052","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of mogamulizumab-associated rash with granuloma annulare-like features in a patient with Sezary syndrome: A case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.06.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}